Lewy body disease is the second most common brain degenerative disease after Alzheimer’s disease. Lewy bodies, deposits of alpha-synuclein protein, are found in the brainstem, limbic system and cerebral cortex. Similar tissue changes are also seen in patients clinically diagnosed with Parkinson’s disease.

Lewy body disease can be difficult to recognise at the beginning of the disease, as it progresses slowly. Symptoms often include movement disturbances, memory problems and psychiatric symptoms.

In their recent study, researchers from the Universities of Helsinki and Tampere investigated for the first time, the occurrence of Lewy body disease markers in young and middle-aged subjects who were not known to suffer from Lewy body or Parkinson’s diseases. Previous similar studies have investigated the occurrence of the disease markers in people over 60 years old.

The researchers found that Lewy body disease changes may begin to develop in the brain already in middle age, even if there are no actual symptoms yet.

“Our findings indicate that Lewy body disease may be more common in people over 50 than previously thought. In the study, we found disease changes in nine percent of people over 50 who did not have a clinical diagnosis of Parkinson’s disease or Lewy body disease. However, further studies are needed to confirm the results,” says Associate Professor Liisa Myllykangas from the University of Helsinki.

Earlier diagnosis means more effective treatment

In their study, the researchers used internationally unique Finnish forensic autopsy data, which consists of approximately 600 people aged 16-95 who died outside hospitals.

Myllykangas says that in the future the treatments developed against degenerative brain diseases will be aimed at patients who are in the early stages of the disease, or are at risk of developing the disease.

“Finding out the prevalence of disease changes in younger age groups is therefore important as this will be the most effective time to start therapies,” she comments.

The study has been published in the journal Annals of Neurology.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is 7 multiplied by 3?

Explore More

Magnetically regulated gene therapy tech offers precise brain-circuit control

A new technology enables the control of specific brain circuits non-invasively with magnetic fields, according to a preclinical study from researchers at Weill Cornell Medicine, The Rockefeller University and the

Brain shrinkage associated with Alzheimer’s therapies shows effectiveness rather than harm

A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue,

Smartphone-assisted wayfinding task identifies people at risk for dementia

Credit: Pixabay/CC0 Public Domain Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia using mobility data, recorded during a smartphone-based wayfinding task